Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...

While Novo Nordisk say they're fighting against stigma, critics say they could be promoting prescription drugs under the ...

Based on an analysis done by the European Medicines Agency on the feasibility of alternatives, the European Commission ...

Sanofi wins EMA's orphan drug status for rilzabrutinib to treat IgG4-RD, a chronic, immune-mediated rare disease.

The White House’s effort to lower drug prices in the U.S. is bringing higher drug prices to Europe. The Indiana-based drugmaker Eli Lilly said on Thursday that it is raising the list prices of its ...

Nowadays in this fast paced life, people are not able to pay much attention to themselves, due to which body weight starts increasing, and the belly bulges out. To avoid this, people are using ...

Introduction Sweden, as many other high-income countries, has adopted guidelines to offer induction of labour at 41+0 gestational weeks to decrease the risk for perinatal death. As more than 20% of ...

The EMA's CHMP said the single pivotal US trial could serve as the basis for a marketing authorization application in the EU.

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the ...

Access Conditionalities And Shortage Measures – A Comparison Of Commission/Parliament/Council Positions. Legal News and ...

The U.S. Food and Drug Administration (FDA) on Tuesday approved Insmed Incorporated’s (NASDAQ:INSM) Brinsupri (brensocatib 10 mg and 25 mg tablets). It is an oral, once-daily treatment for non-cystic ...